Technological advances are opening up new drug development opportunities for rare diseases.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

The material composition of consumables – whether plastic or glass – impacts their carbon footprints. But which is more efficient?

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

How a LEGO biomanufacturing facility brought out the inner child in attendees at an industry trade show.

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

EFPIA signs joint declaration championing open trade in the EU.

We dive into the archive of 2018 for insight and inspiration – this time with Bruno Sepodes

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.